192 related articles for article (PubMed ID: 9795288)
1. [Quinolone resistance in Salmonella enterica].
Seral C; López L; Castillo FJ; Clavel A; Rubio MC
Rev Esp Quimioter; 1998 Mar; 11(1):43-6. PubMed ID: 9795288
[TBL] [Abstract][Full Text] [Related]
2. [Evolution of resistance to quinolones in Salmonella enterica in our setting].
Ruiz M; Sirvent E; Hernández C; Rodríguez JC; Royo G
Rev Esp Quimioter; 1999 Dec; 12(4):366-8. PubMed ID: 10855017
[TBL] [Abstract][Full Text] [Related]
3. Increasing incidence of quinolone resistance in human non-typhoid Salmonella enterica isolates in Korea and mechanisms involved in quinolone resistance.
Choi SH; Woo JH; Lee JE; Park SJ; Choo EJ; Kwak YG; Kim MN; Choi MS; Lee NY; Lee BK; Kim NJ; Jeong JY; Ryu J; Kim YS
J Antimicrob Chemother; 2005 Dec; 56(6):1111-4. PubMed ID: 16244086
[TBL] [Abstract][Full Text] [Related]
4. New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility.
Hakanen AJ; Lindgren M; Huovinen P; Jalava J; Siitonen A; Kotilainen P
J Clin Microbiol; 2005 Nov; 43(11):5775-8. PubMed ID: 16272517
[TBL] [Abstract][Full Text] [Related]
5. [Multidrug resistance to antibacterial drugs of Salmonella enterica subsp. enterica strains isolated in Poland in the 1998-1999 period].
Szych J; Cieślik A; Paciorek J; Kałuzewski S
Med Dosw Mikrobiol; 2001; 53(1):17-29. PubMed ID: 11757401
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of nalidixic acid resistance for detecting salmonellae with decreased ciprofloxacin susceptibility.
Albayrak F; Cokca F; Erdem B; Aysev AD
Int J Antimicrob Agents; 2004 Apr; 23(4):332-6. PubMed ID: 15081080
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the gyrA gene in Salmonella enterica clinical isolates with decreased ciprofloxacin susceptibility.
Escribano I; Rodríguez JC; Royo G
Int J Antimicrob Agents; 2004 Sep; 24(3):300-3. PubMed ID: 15325438
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological analysis of Salmonella enterica ssp. enterica serovars Hadar, Brancaster and Enteritidis from humans and broiler chickens in Senegal using pulsed-field gel electrophoresis and antibiotic susceptibility.
Cardinale E; Perrier Gros-Claude JD; Rivoal K; Rose V; Tall F; Mead GC; Salvat G
J Appl Microbiol; 2005; 99(4):968-77. PubMed ID: 16162250
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial resistance in clinical isolates of Salmonella enterica serotype Enteritidis: relationships between mutations conferring quinolone resistance, integrons, plasmids and genetic types.
Soto SM; González-Hevia MA; Mendoza MC
J Antimicrob Chemother; 2003 May; 51(5):1287-91. PubMed ID: 12668577
[TBL] [Abstract][Full Text] [Related]
10. Clonal expansion may account for high levels of quinolone resistance in Salmonella enterica serovar enteritidis.
Kilmartin D; Morris D; O'Hare C; Corbett-Feeney G; Cormican M
Appl Environ Microbiol; 2005 May; 71(5):2587-91. PubMed ID: 15870349
[TBL] [Abstract][Full Text] [Related]
11. [Antimicrobial resistance of clinical strains of Salmonella enterica isolated in Zaragoza].
Olivera S; Castillo FJ; Llorente MT; Clavel A; Varea M; Seral C; Rubio MC
Rev Esp Quimioter; 2002 Jun; 15(2):152-7. PubMed ID: 12582444
[TBL] [Abstract][Full Text] [Related]
12. Low-level quinolone-resistance in multi-drug resistant typhoid.
Mirza SH; Khan MA
J Coll Physicians Surg Pak; 2008 Jan; 18(1):13-6. PubMed ID: 18452661
[TBL] [Abstract][Full Text] [Related]
13. Incidence of quinolone resistance over the period 1986 to 1998 in veterinary Salmonella isolates from Germany.
Malorny B; Schroeter A; Helmuth R
Antimicrob Agents Chemother; 1999 Sep; 43(9):2278-82. PubMed ID: 10471579
[TBL] [Abstract][Full Text] [Related]
14. Increasing prevalence of quinolone resistance in human nontyphoid Salmonella enterica isolates obtained in Spain from 1981 to 2003.
Marimón JM; Gomáriz M; Zigorraga C; Cilla G; Pérez-Trallero E
Antimicrob Agents Chemother; 2004 Oct; 48(10):3789-93. PubMed ID: 15388435
[TBL] [Abstract][Full Text] [Related]
15. Nalidixic acid resistance in Salmonella strains with decreased susceptibility to ciprofloxacin isolated from humans in Turkey.
Ercis S; Erdem B; Hasçelik G; Gür D
Jpn J Infect Dis; 2006 Apr; 59(2):117-9. PubMed ID: 16632912
[TBL] [Abstract][Full Text] [Related]
16. Trends in nalidixic acid resistance in nontyphoidal Salmonella isolated from 1999 to 2002: decreased susceptibility to 6 fluoroquinolones.
Rodriguez-Avial I; Rodriguez-Avial C; López O; Picazo JJ
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):261-4. PubMed ID: 15893900
[TBL] [Abstract][Full Text] [Related]
17. Detection of novel gyrA mutations in nalidixic acid-resistant isolates of Salmonella enterica from patients with diarrhoea.
Hamidian M; Tajbakhsh M; Tohidpour A; Rahbar M; Zali MR; Walther-Rasmussen J
Int J Antimicrob Agents; 2011 Apr; 37(4):360-4. PubMed ID: 21371866
[TBL] [Abstract][Full Text] [Related]
18. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.
Butt T; Khan MY; Ahmad RN; Salman M; Afzal RK
J Coll Physicians Surg Pak; 2006 Jan; 16(1):31-4. PubMed ID: 16441985
[TBL] [Abstract][Full Text] [Related]
19. Increase in nalidixic acid resistance among non-Typhi Salmonella enterica isolates in the United States from 1996 to 2003.
Stevenson JE; Gay K; Barrett TJ; Medalla F; Chiller TM; Angulo FJ
Antimicrob Agents Chemother; 2007 Jan; 51(1):195-7. PubMed ID: 17088493
[TBL] [Abstract][Full Text] [Related]
20. Ciprofloxacin resistance in non-typhoidal Salmonella serotypes in Scotland, 1993-2003.
Murray A; Coia JE; Mather H; Brown DJ
J Antimicrob Chemother; 2005 Jul; 56(1):110-4. PubMed ID: 15914492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
